Del 6
Pharma M&A versus alliances and its underlying value drivers
Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective
739 kr
Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.
Beskrivning
From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.
Produktinformation
Utforska kategorier
Mer om författaren
Innehållsförteckning
Hoppa över listan
Mer från samma serie
Del 5
Creating and Governing an Integrated Market for Retail Banking Services in Europe
Matthäus Markus Sielecki
Inbunden, 2011
886 kr
Del 9
Del 10
Mergers and Acquisitions in the Global Brewing Industry
Ramit Mehta, Dirk Schiereck
Inbunden, 2012
917 kr
Del 12
Del 13
Del 14
Del 18
Del 21
Del 16
Hoppa över listan
Du kanske också är intresserad av
Del 7
Del 13
Del 17
Del 12
- Signerad!
Del 3
- Nyhet
Del 19
Erklaerungsansaetze fuer NAV-Spreads und deren Implikationen fuer das Management von REITs
Michael Müller, Dirk Schiereck
Häftad, 2015
1 007 kr
Del 20
Del 6
Del 2